 Achieve Life Sciences Inc NASDAQ: ACHV has priced its underwritten public offering of 2.9 million at 7 per share, representing a discount of 19 from the last close price of 8.61. Underwriters have a 30-day option to purchase up to an additional 428 thousand shares. 